相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
Alireza Atri et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD
Rainer Hellweg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
A review of the effects of memantine on clinical progression in Alzheimer's disease
David Wilkinson
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Is delay of clinical worsening a valuable goal in the treatment of Alzheimer's disease?
R. Berghmans
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies
Alireza Atri et al.
NEURODEGENERATIVE DISEASES (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Determining the minimum clinically important differences for outcomes in the DOMINO trial
Robert Howard et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease
Kenneth Rockwood et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients
Steven Ferris et al.
ALZHEIMERS & DEMENTIA (2009)
Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Long-term course and effectiveness of combination therapy in Alzheimer disease
Alireza Atri et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
Anton P. Porsteinsson et al.
CURRENT ALZHEIMER RESEARCH (2008)
Memantine for the treatment of Alzheimer's disease
Martin R. Farlow et al.
DRUG SAFETY (2008)
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis
S. Gauthier et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
Dennis Revicki et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease
Christopher H. van Dyck et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Meta-analysis of six-month memantine trials in Alzheimer's disease
Rachelle Smith Doody et al.
ALZHEIMERS & DEMENTIA (2007)
Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Memantine in moderate to severe Alzheimer's disease: a meta-analysis of randomised clinical trials
Bengt Winblad et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
Elaine R. Peskind et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
CH van Dyck et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease
D Galasko et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2005)
Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition
OL Lopez et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success
B Winblad et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2001)
分享论文
